Prothrombotic state in churg-strauss syndrome: A case report

Journal of Investigational Allergology and Clinical Immunology

Volumn 20, Issue 7, 2010, Pages 616-619

  Marzano, Av ^a   Tedeschi, A ^b   Rossio, R ^a   Fanoni, D ^a   Cugno, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Churg strauss syndrome; Eosinophil; Thrombosis; Tissue factor

Indexed keywords

AZATHIOPRINE; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; CYCLOPHOSPHAMIDE; D DIMER; EOSINOPHIL CATIONIC PROTEIN; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

ADULT; ANAMNESIS; ANTIBODY BLOOD LEVEL; ARTICLE; ASTHMA; CASE REPORT; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; DRUG DOSE REDUCTION; DRUG EFFICACY; EOSINOPHILIA; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY INFILTRATE; LEUKOCYTOCLASTIC VASCULITIS; MAINTENANCE THERAPY; MALE; PERIPHERAL NEUROPATHY; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; REMISSION; SINUSITIS; SKIN BIOPSY; SKIN NODULE; SKIN ULCER; THROMBOSIS;

ADULT; CHURG-STRAUSS SYNDROME; EOSINOPHILIA; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PEPTIDE FRAGMENTS; PROTHROMBIN; SKIN DISEASES; THROMBOPLASTIN; THROMBOSIS;

EID: 79251511989     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Liao YH, Su YW, Tsay W, Chiu HC. Association of cutaneous necrotizing eosinophilic vasculitis and deep vein thrombosis in hypereosinophilic syndrome. Arch Dermatol. 2005;141:1051-1053.
2. Liapis H, Ho AK, Brown D, Mindel G, Gleich G. Thrombotic microangiopathy associated with the hypereosinophilic syndrome. Kidney Int. 2005;67:1806-1811.
3. Ogbogu P, Rosing DR, Horne MK III. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am. 2007;27:457-475.
4. Watts RA, Lane SE, Bentham G, Scott DG: Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum. 2000;43:414-419.
5. Noth I, Strek ME, Leff AR. Churg-Strauss syndrome. Lancet. 2003;361:587-594.
6. Phillip R, Luqmani R. Mortality in systemic vasculitis: a systematic review. Clin Exp Rheumatol. 2008;26:S94-104.
7. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome: clinical study and long-term followup of 96 patients. Medicine (Baltimore). 1999;78:26-37.
8. Garcia G, Achouh L, Cobarzan D, Fichet D, Humbert M. Severe thromboembolic disease in Churg-Strauss syndrome. Allergy. 2005;60:409-410.
9. Allenbach Y, Seror R, Pagnoux C, Teixeira L, Guilpain P, Guillevin L, French Vasculitis Study Group. High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients. Ann Rheum Dis. 2009;68;564-567.
10. Moosbauer C, Morgenstern E, Cuvelier SL, Manukyan D, Bidzhekov K, Albrecht S, Lohse P, Patel KD, Engelmann B. Eosinophils are a major intravascular location for tissue factor storage and exposure. Blood. 2007;109:995-1002.
11. Marzano AV, Tedeschi A, Fanoni D, Bonanni E, Venegoni L, Berti E, Cugno M. Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications. Br J Dermatol. 2009;160:266-272.
12. Marzano AV, Tedeschi A, Spinelli D, Fanoni D, Crosti C, Cugno M. Coagulation activation in autoimmune bullous diseases. Clin Exp Immunol. 2009;158:31-36.
13. Lippi G, Montagnana M, Salvagno GL, Franchini M, Targher G, Guidi GC. Eosinophilia and first-line coagulation testing. J Thromb Thrombolysis. 2009;28:90-93.
14. Ota S, Wada H, Abe Y, Yamada E, Sakaguchi A, Nishioka J, Hatada T, Ishikura K, Yamada N, Sudo A, Uchida A, Nobori T. Elevated levels of prothrombin fragment 1+2 indicate high risk of thrombosis. Clin Appl Thromb Hemost. 2008;14:279-285.
15. Pabinger I, Ay C. Biomarkers and venous thromboembolism. Arterioscler Thromb Vasc Biol. 2009;29:332-336.